The Infinium Pharmachem date has been confirmed from March 31 and ended on April 5
Infinium Pharmachem IPO worth Rs. 25.31 crore from 1,875,000 equity shares will open for subscription on March 31, 2023. The fixed-issue IPO will be available in the price band of Rs. 135 per share with 1000 shares per lot.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
March 31 – April 5
Price Range
₹135 per share
Face Value
₹10 per share
GMP
₹2
Infinium Pharmachem GMP
The Infinium Pharmachem IPO GMP is ₹[2].
IPO Overview
Infinium Pharmachem IPO is a fixed price issue of Rs 25.26 crores. The issue is entirely a fresh issue of 18.75 lakh shares.
Infinium Pharmachem IPO bidding started from March 31, 2023 and ended on April 5, 2023. The allotment for Infinium Pharmachem IPO was finalized on Tuesday, April 11, 2023. The shares got listed on NSE SME on April 17, 2023.
Infinium Pharmachem IPO price is ₹135 per share. The minimum lot size for an application is 1000 Shares. The minimum amount of investment required by retail investors is ₹135,000. The minimum lot size investment for HNI is 2 lots (2,000 shares) amounting to ₹270,000.
Infinium Pharmachem IPO Date & Price Band Details
| IPO Date | March 31, 2023 to April 5, 2023 |
| Listing Date | April 17, 2023 |
| Face Value | ₹10 per share |
| Price | ₹135 per share |
| Lot Size | 1000 Shares |
| Total Issue Size | 1,875,000 shares (aggregating up to ₹25.26 Cr) |
| Fresh Issue | 1,875,000 shares (aggregating up to ₹25.26 Cr) |
| Employee Discount | Rs 13.5 per share |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Market Maker portion | 94,000 shares |
Infinium Pharmachem IPO Market Lot
Investors can bid for a minimum of 1000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Applications | Lots | Shares | Amount |
| Retail (Min) | 1 | 1000 | ₹135,000 |
| Retail (Max) | 1 | 1000 | ₹135,000 |
| HNI (Min) | 2 | 2,000 | ₹270,000 |
Infinium Pharmachem IPO Allotment & Listing Dates
Infinium Pharmachem IPO opens on March 31, 2023, and closes on April 5, 2023.
| IPO Open Date | Friday, March 31, 2023 |
| IPO Close Date | Wednesday, April 5, 2023 |
| Basis of Allotment | Tuesday, April 11, 2023 |
| Initiation of Refunds | Wednesday, April 12, 2023 |
| Credit of Shares to Demat | Thursday, April 13, 2023 |
| Listing Date | Monday, April 17, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on April 5, 2023 |
Infinium Pharmachem Company Financial Report
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Total Borrowing |
| 31-Mar-20 | 2,244.60 | 3,941.64 | 93.40 | 424.74 | 566.17 |
| 31-Mar-21 | 3,418.27 | 7,115.37 | 272.48 | 702.32 | 579.47 |
| 31-Mar-22 | 5,899.95 | 10,005.25 | 610.64 | 1,310.22 | 1,385.01 |
| 30-Sep-22 | 7,075.71 | 7,985.39 | 551.01 | 1,855.77 | 1,614.71 |
Infinium Pharmachem Company Financials
| Particulars | Year ending on March 31, 2022 (₹ Lakh) | Year ending on March 31, 2021 (₹ Lakh) | Year ending on March 31, 2020 (₹ Lakh) |
| Revenue from Operations | 7,403.77 | 5,455.79 | 3,603.84 |
| Profit After Tax (PAT) | 550.34 | 271.94 | 101.81 |
| EBITDA | 1096.60 | 557.60 | 305.82 |
| EPS | 60.07 | 26.80 | 9.19 |
| Period Ended | As on March 31, 2022 (₹ Lakh) | As on March 31, 2021 (₹ Lakh) | As on March 31, 2020 (₹ Lakh) |
| Current Asset | 3,393.30 | 2,231.01 | 1,605.09 |
| Current Liabilities | 2,288.31 | 1,796.98 | 1,060.64 |
Company Profile
At Infinium Pharmachem Limited, we are well-focused on Iodine chemistry & this is our only core area. We are working as CRAMS, but our domain is very restricted to Iodine chemistry & it revolves around Iodine derivatives or Iodination. We have manufactured & supplied a wide range of superior-quality Iodine Derivatives & APIs since 2003. We also provide fully integrated customized services from R & D to Commercial scale manufacturing and packaging for our products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & various other chemical Industries. We supply a range of Iodine derivatives on an order-to-make basis only. However, we keep in ready stock many of the well-in-demand products.
Infinium always welcomes any specific customisation enquiry concerning quality specification/s, packing, labelling, testing (MOA) & analysis &/OR shipment schedule. Our Technical Team will be happy to extend full technical support.
Registrar Info
| Name | Bigshare Services Pvt Ltd |
| Phone number | +91-22-6263 8200 |
| Email ID | ipo@bigshareonline.com |
| Website | https://ipo.bigshareonline.com/ipo_status.html |
Contact Details
| Name | Infinium Pharmachem Limited |
| Phone number | +91-2692-238849 |
| Email ID | info@infiniumpharmachem.com |
| Website | https://infiniumpharmachem.com/ |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
